PIII has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PIII has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, P3 Health Partners's Enterprise Value is $255 Mil. P3 Health Partners's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $-230 Mil. Therefore, P3 Health Partners's EV-to-EBIT for today is -1.11.
The historical rank and industry rank for P3 Health Partners's EV-to-EBIT or its related term are showing as below:
During the past 6 years, the highest EV-to-EBIT of P3 Health Partners was -0.41. The lowest was -25.99. And the median was -2.09.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. P3 Health Partners's Enterprise Value for the quarter that ended in Sep. 2024 was $288 Mil. P3 Health Partners's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $-230 Mil. P3 Health Partners's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -79.89%.
The historical data trend for P3 Health Partners's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
EV-to-EBIT | Get a 7-Day Free Trial | - | - | - | -0.44 | -3.23 |
P3 Health Partners Quarterly Data | |||||||||||||||||||
Dec18 | Dec19 | Jun20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
EV-to-EBIT | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-0.87 | -3.23 | -2.87 | -2.13 | -1.25 |
For the Medical Care Facilities subindustry, P3 Health Partners's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's EV-to-EBIT falls into.
P3 Health Partners's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 255.077 | / | -229.75 | |
= | -1.11 |
P3 Health Partners's current Enterprise Value is $255 Mil.
P3 Health Partners's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-230 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners (NAS:PIII) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
P3 Health Partners's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 ) | = | EBIT | / | Enterprise Value (Q: Sep. 2024 ) |
= | -229.75 | / | 287.5987836 | |
= | -79.89 % |
P3 Health Partners's Enterprise Value for the quarter that ended in Sep. 2024 was $288 Mil.
P3 Health Partners's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-230 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of P3 Health Partners's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Chicago Pacific Founders Ugp Iii, Llc | 10 percent owner | 980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Atul Kavthekar | officer: Chief Financial Officer | 4100 S. SAGINAW STREET, FLINT MI 48507 |
Sherif Abdou | director, officer: Chief Executive Officer | C/O P3 HEALTH GROUP HOLDINGS, LLC, 2370 CORPORATE CIRCLE, SUITE 300, HENDERSON NV 89074 |
Chicago Pacific Founders Gp Iii, L.p. | 10 percent owner | 980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Chicago Pacific Founders Ugp, Llc | 10 percent owner | 980 N. MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Leavitt Equity Partners Ii, L.p. | 10 percent owner | 299 SOUTH MAIN STREET SUITE 2300, SALT LAKE CITY UT 84111 |
Leavitt Legacy, Llc | 10 percent owner | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Leavitt Equity Partners Ii, Llc | 10 percent owner | 299 SOUTH MAIN STREET SUITE 2300, SALT LAKE CITY UT 84111 |
Lep Management Llc | 10 percent owner | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Taylor S. Leavitt | 10 percent owner | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Leavitt Equity Partners Iii, L.p. | 10 percent owner, other: See Remarks | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Leavitt Equity Partners Iii, Llc | 10 percent owner, other: See Remarks | 299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Cpf Iii-a Pt Spv, Llc | 10 percent owner | 980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Cpf Iii Pt Spv, Llc | 10 percent owner | 980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611 |
Erin Darakjian | officer: Interim CFO, Senior VP & CAO | C/O P3 HEALTH PARTNERS INC., 2370 CORPORATE CIRCLE, SUITE 300, HENDERSON NV 89074 |
From GuruFocus
By Marketwired • 02-10-2025
By GuruFocus News • 11-15-2024
By GuruFocus News • 10-09-2024
By GuruFocus Research • 08-08-2024
By PRNewswire • 12-19-2024
By GuruFocus News • 10-09-2024
By Business Wire • 05-23-2024
By Business Wire • 11-27-2024
By Business Wire • 08-07-2024
By Business Wire • 07-24-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.